Opioid Narcotics Industry Research Report 2025

Summary

According to APO Research, the global Opioid Narcotics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Opioid Narcotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Narcotics.

The report will help the Opioid Narcotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Opioid Narcotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Narcotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Opioid Narcotics Segment by Company

Yichang Renfu Pharmaceutical Co., Ltd.
Jiangsu Enhua Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Sinopharm Group Industrial Co., Ltd. Langfang Branch
Changzhou Siyao Pharmaceutical Co., Ltd.
Reig Jofre
Pfizer
GSK
Fresenius Kabi
Daiichi Sankyo
AcelRx Pharmaceuticals, Inc
Abbott
Opioid Narcotics Segment by Type

Fentanyl
Remifentanil
Sufentanil
Opioid Narcotics Segment by Application

Hospital
Clinic
Other
Opioid Narcotics Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Opioid Narcotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Opioid Narcotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Opioid Narcotics Market Size (2020-2031)
2.2.2 Global Opioid Narcotics Sales (2020-2031)
2.2.3 Global Opioid Narcotics Market Average Price (2020-2031)
2.3 Opioid Narcotics by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Fentanyl
2.3.3 Remifentanil
2.3.4 Sufentanil
2.4 Opioid Narcotics by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Opioid Narcotics Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Opioid Narcotics Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Opioid Narcotics Revenue of Manufacturers (2020-2025)
3.4 Global Opioid Narcotics Average Price by Manufacturers (2020-2025)
3.5 Global Opioid Narcotics Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Opioid Narcotics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Opioid Narcotics, Product Type & Application
3.8 Global Manufacturers of Opioid Narcotics, Established Date
3.9 Global Opioid Narcotics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Yichang Renfu Pharmaceutical Co., Ltd.
4.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
4.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
4.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
4.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
4.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
4.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
4.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
4.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
4.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
4.3 Henan Lingrui Pharmaceutical Co., Ltd.
4.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
4.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
4.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
4.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
4.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
4.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
4.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
4.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
4.5 Changzhou Siyao Pharmaceutical Co., Ltd.
4.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
4.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
4.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
4.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
4.6 Reig Jofre
4.6.1 Reig Jofre Company Information
4.6.2 Reig Jofre Business Overview
4.6.3 Reig Jofre Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Reig Jofre Opioid Narcotics Product Portfolio
4.6.5 Reig Jofre Recent Developments
4.7 Pfizer
4.7.1 Pfizer Company Information
4.7.2 Pfizer Business Overview
4.7.3 Pfizer Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Pfizer Opioid Narcotics Product Portfolio
4.7.5 Pfizer Recent Developments
4.8 GSK
4.8.1 GSK Company Information
4.8.2 GSK Business Overview
4.8.3 GSK Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.8.4 GSK Opioid Narcotics Product Portfolio
4.8.5 GSK Recent Developments
4.9 Fresenius Kabi
4.9.1 Fresenius Kabi Company Information
4.9.2 Fresenius Kabi Business Overview
4.9.3 Fresenius Kabi Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
4.9.5 Fresenius Kabi Recent Developments
4.10 Daiichi Sankyo
4.10.1 Daiichi Sankyo Company Information
4.10.2 Daiichi Sankyo Business Overview
4.10.3 Daiichi Sankyo Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
4.10.5 Daiichi Sankyo Recent Developments
4.11 AcelRx Pharmaceuticals, Inc
4.11.1 AcelRx Pharmaceuticals, Inc Company Information
4.11.2 AcelRx Pharmaceuticals, Inc Business Overview
4.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
4.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
4.12 Abbott
4.12.1 Abbott Company Information
4.12.2 Abbott Business Overview
4.12.3 Abbott Opioid Narcotics Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Abbott Opioid Narcotics Product Portfolio
4.12.5 Abbott Recent Developments
5 Global Opioid Narcotics Market Scenario by Region
5.1 Global Opioid Narcotics Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Opioid Narcotics Sales by Region: 2020-2031
5.2.1 Global Opioid Narcotics Sales by Region: 2020-2025
5.2.2 Global Opioid Narcotics Sales by Region: 2026-2031
5.3 Global Opioid Narcotics Revenue by Region: 2020-2031
5.3.1 Global Opioid Narcotics Revenue by Region: 2020-2025
5.3.2 Global Opioid Narcotics Revenue by Region: 2026-2031
5.4 North America Opioid Narcotics Market Facts & Figures by Country
5.4.1 North America Opioid Narcotics Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Opioid Narcotics Sales by Country (2020-2031)
5.4.3 North America Opioid Narcotics Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Opioid Narcotics Market Facts & Figures by Country
5.5.1 Europe Opioid Narcotics Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Opioid Narcotics Sales by Country (2020-2031)
5.5.3 Europe Opioid Narcotics Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Opioid Narcotics Market Facts & Figures by Country
5.6.1 Asia Pacific Opioid Narcotics Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Opioid Narcotics Sales by Country (2020-2031)
5.6.3 Asia Pacific Opioid Narcotics Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Opioid Narcotics Market Facts & Figures by Country
5.7.1 South America Opioid Narcotics Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Opioid Narcotics Sales by Country (2020-2031)
5.7.3 South America Opioid Narcotics Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.7.7 Colombia
5.8 Middle East and Africa Opioid Narcotics Market Facts & Figures by Country
5.8.1 Middle East and Africa Opioid Narcotics Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Opioid Narcotics Sales by Country (2020-2031)
5.8.3 Middle East and Africa Opioid Narcotics Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Opioid Narcotics Sales by Type (2020-2031)
6.1.1 Global Opioid Narcotics Sales by Type (2020-2031) & (K Units)
6.1.2 Global Opioid Narcotics Sales Market Share by Type (2020-2031)
6.2 Global Opioid Narcotics Revenue by Type (2020-2031)
6.2.1 Global Opioid Narcotics Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Opioid Narcotics Revenue Market Share by Type (2020-2031)
6.3 Global Opioid Narcotics Price by Type (2020-2031)
7 Segment by Application
7.1 Global Opioid Narcotics Sales by Application (2020-2031)
7.1.1 Global Opioid Narcotics Sales by Application (2020-2031) & (K Units)
7.1.2 Global Opioid Narcotics Sales Market Share by Application (2020-2031)
7.2 Global Opioid Narcotics Revenue by Application (2020-2031)
7.2.1 Global Opioid Narcotics Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Opioid Narcotics Revenue Market Share by Application (2020-2031)
7.3 Global Opioid Narcotics Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Opioid Narcotics Value Chain Analysis
8.1.1 Opioid Narcotics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Opioid Narcotics Production Mode & Process
8.2 Opioid Narcotics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Opioid Narcotics Distributors
8.2.3 Opioid Narcotics Customers
9 Global Opioid Narcotics Analyzing Market Dynamics
9.1 Opioid Narcotics Industry Trends
9.2 Opioid Narcotics Industry Drivers
9.3 Opioid Narcotics Industry Opportunities and Challenges
9.4 Opioid Narcotics Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings